Reportlinker.com announces that a new market research report is available in its catalogue.
Evolving Trends in Biopharmaceutical Licensing: Deal assessments, drivers and resistors
http://www.reportlinker.com/p0114852/Evolving-Trends-in-Biopharmaceutical-Licensing-Deal-assessments-drivers-and-resistors.html
Evolving Trends in Biopharmaceutical Licensing: Deal assessments, drivers and resistors
Large Pharma companies have become heavily dependant upon alliances and in-licensing to gain access to technologies/new molecular entities from Biopharma. This reliance has strengthened Biopharma’s bargaining position, and is reflected in negotiation tactics which aim to expand their role beyond product discovery and development towards an active participation in the the future of their products. This is emphasized by the growing complexity of licensing deals, as Biopharma attempts to secure marketing and commercialization rights within partnership deals.
Furthermore, recent increases in internal Biopharma consolidation are an indicator of the ability of well-established Biopharma companies to effectively compete against traditional big Pharma.
‘Evolving Trends in Biopharmaceutical Licensing’ is a report published by Business Insights that provides a detailed analysis of licensing strategies in the biopharmaceutical industry over the 2001-08 period. This report examines the growth of the biopharmaceutical industry, deal-making trend data, drivers and challenges facing biopharmaceutical licensing, and profiles of biopharmaceutical licensing among leading companies. The future prospects of the industry are assessed and the potential impact of political/regulatory factors upon licensing and alliances is identified. This report also investigates the influence of the recent upsurge in M&A activity and provides recommendations on the strategies that can sustain future growth.
Key Findings